Authors/Disclosures
|
Jose L. Ruiz-Sandoval, MD
|
Dr. Ruiz-Sandoval has nothing to disclose. |
|
|
No disclosure on file |
|
John Parker, MD
(RealTime Neuromonitoring Associates)
|
No disclosure on file |
|
|
No disclosure on file |
|
Rachel Pearson, MD
(Children's Hospital Orange County)
|
Dr. Pearson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Pearson has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Pediatric Subspecialty Faculy. The institution of Dr. Pearson has received research support from Pediatric Subspecialty Faculty. |
|
Fernando Barinagarrementeria, MD, FAAN
(Hospital H+ Queretaro)
|
No disclosure on file |
|
Tahseen Mozaffar, MD, FAAN
(University of California Irvine)
|
Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. |
|
Erwin Chiquete, MD, PhD
|
No disclosure on file |
|
|
No disclosure on file |
|
Carolina Leon Jimenez, MD
(Merz Pharma SA de CV)
|
No disclosure on file |
|
|
No disclosure on file |
|
Antonio Arauz, MD, PhD
(Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez)
|
Dr. Arauz has nothing to disclose. |
|
|
No disclosure on file |
|
John M. Ringman, MD, FAAN
(Keck School of Medicine of USC, Neurology Dept)
|
The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP. |